These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29134556)

  • 1. Process optimization and particle engineering of micronized drug powders via milling.
    Brunaugh A; Smyth HDC
    Drug Deliv Transl Res; 2018 Dec; 8(6):1740-1750. PubMed ID: 29134556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying Dry Milling in Pharmaceutical Processing: A Review on Experimental and Modeling Approaches.
    Naik S; Chaudhuri B
    J Pharm Sci; 2015 Aug; 104(8):2401-13. PubMed ID: 26096636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different modes of dynamic image analysis in monitoring of pharmaceutical dry milling process.
    Nalluri VR; Schirg P; Gao X; Virdis A; Imanidis G; Kuentz M
    Int J Pharm; 2010 May; 391(1-2):107-14. PubMed ID: 20188807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jet milling industrialization of sticky active pharmaceutical ingredient using quality-by-design approach.
    Nakach M; Authelin JR; Corsini C; Gianola G
    Pharm Dev Technol; 2019 Sep; 24(7):849-863. PubMed ID: 30998419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.
    Siewert C; Moog R; Alex R; Kretzer P; Rothenhäusler B
    Eur J Pharm Sci; 2018 Mar; 115():126-131. PubMed ID: 29278757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE).
    Nekkanti V; Marwah A; Pillai R
    Drug Dev Ind Pharm; 2015 Jan; 41(1):124-30. PubMed ID: 24180259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies.
    Rogers TL; Johnston KP; Williams RO
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1003-15. PubMed ID: 11794803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of particle shape of active pharmaceutical ingredients prepared by fluidized-bed jet-milling on cohesiveness.
    Fukunaka T; Sawaguchi K; Golman B; Shinohara K
    J Pharm Sci; 2005 May; 94(5):1004-12. PubMed ID: 15793798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical excipients properties and screw feeder performance in continuous processing lines: a Quality by Design (QbD) approach.
    Santos B; Carmo F; Schlindwein W; Muirhead G; Rodrigues C; Cabral L; Westrup J; Pitt K
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2089-2097. PubMed ID: 30113219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of grinding balls on the size reduction of Aprepitant in wet ball milling procedure.
    Memarvar D; Yaqoubi S; Hamishehkar H; Lam M; Nokhodchi A
    Pharm Dev Technol; 2024 Apr; 29(4):353-358. PubMed ID: 38528824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach.
    Bartos C; Pallagi E; Szabó-Révész P; Ambrus R; Katona G; Kiss T; Rahimi M; Csóka I
    Eur J Pharm Sci; 2018 Oct; 123():475-483. PubMed ID: 30076956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.
    Branham ML; Moyo T; Govender T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):194-202. PubMed ID: 21906676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology--a QbD perspective.
    Ghosh I; Schenck D; Bose S; Liu F; Motto M
    Pharm Dev Technol; 2013; 18(3):719-29. PubMed ID: 23061898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of powder processing on performance of fenofibrate formulations.
    Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Product Development, Manufacturing, and Packaging of Solid Dosage Forms Under QbD and PAT Paradigm: DOE Case Studies for Industrial Applications.
    Singh BN
    AAPS PharmSciTech; 2019 Sep; 20(8):313. PubMed ID: 31529232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of acetaminophen particle attributes using a wet milling crystallisation platform.
    Ahmed B; Brown CJ; McGlone T; Bowering DL; Sefcik J; Florence AJ
    Int J Pharm; 2019 Jan; 554():201-211. PubMed ID: 30391338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Approach and Practical Modelling of Bead Milling Process for the Manufacturing of Nanocrystalline Suspensions.
    Nakach M; Authelin JR; Agut C
    J Pharm Sci; 2017 Jul; 106(7):1889-1904. PubMed ID: 28302540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.